Molecular genetics and epidemiology of Japanese type 1 diabetes

Current Pharmacogenomics

Volumn 3, Issue 3, 2005, Pages 191-199

  Kawasaki, Eiji ^a   Eguchi, Katsumi ^b  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Autoantibodies; Autoantigen; Genetics; Heterogeneity; Immunology; Type 1 diabetes

Indexed keywords

AMINO ACID DERIVATIVE; ANTIDIABETIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; NBI 6024; NEUROGENIC DIFFERENTIATION FACTOR; NICOTINAMIDE; PLACEBO; PROTEIN TYROSINE PHOSPHATASE; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CAUCASIAN; CLINICAL TRIAL; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEREDITY; HIGH RISK POPULATION; HUMAN; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MOLECULAR GENETICS; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHARMACOGENETICS; PREDICTION; RAT STRAIN; REVIEW; T LYMPHOCYTE;

ANIMALIA;

EID: 23844471794     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570160054864030     Document Type: Review

References (84)

1. Abe, T.; Takino, H.; Yamasaki, H.; Ozaki, M.; Sera, Y.; Kondo, H.; Sakamaki, H.; Kawasaki, E.; Awata, T.; Yamaguchi, Y. and Eguchi, K. (1999) CTLA4 gene polymorpbism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res. Clin. Pract. 46, 169-175.
2. Abe, T.; Yamaguchi, Y.; Takino, H.; Fujita, N.; Yamauchi, D. M.; Ozaki, M.; Yamakawa, K.; Sera, Y.; Sakamaki, H.; Uotani, S.; Kawasaki, E.; Awata, T.; Yamasaki, H. and Eguchi, K. (2001) CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody. Diabet. Med. 18, 726-731.
3. Abiru, N.; Takino, H.; Yano, M.; Kawasaki, E.; Yamasaki, H.; Yamaguchi, Y.; Akazawa, S. and Nagataki, S. (1996) Clinical evaluation of non-insulin-deoendent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase. J. Autoimmun. 9, 683-688.
4. Alberti, K. G. M. M.; Zimmet, P. Z.; for the WHO Consultation. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet. Med. 15, 539-553.
5. Alleva, D. G.; Gaur, A.; Jin, L.; Wegmann, D.; Gottlieb, P. A.; Pahuja, A.; Johnson, E. B.; Motheral, T.; Putnam, A.; Crowe, P. D.; Ling, N.; Boehme, S. A. and Conlon, P. J. (2002) Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes 51, 2126-2134.
6. Atkinson, M.; Maclaren, N.; Luchetta, R. and Burr, I. (1990) Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39, 933-937.
7. Awata, T. and Kanazawa, Y. (1994) Genetic markers for insulin-dependent diabetes mellitus in Japanese. Diabetes Res. Clin. Pract. 24, S83-S87.
8. Awata, T.; Kurihara, S.; Iitaka, M.; Takei, S.; Inoue, I.; Ishii, C.; Negishi, K.; Izumida, T.; Yoshida, Y.; Hagura, R.; Kuzuya, N.; Kanazawa, Y. and Katayama, S. (1998) Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47, 128-129.
9. Awata, T.; Kurihara, S.; Kikuchi, C.; Takei, S.; Inoue, I.; Ishii, C.; Takahashi, K.; Negishi, K.; Yoshida, Y.; Hagura, R.; Kanazawa, Y. and Katayama, S. (1997) Evidence for association between the class I subset of the insulin gene minisatellite (IDDM2 locus) and IDDM in the Japanese population. Diabetes 46, 1637-1642.
10. Awata, T.; Kuzuya, T.; Matsuda, A.; Iwamoto, Y. and Kanazawa, Y. (1992) Genetic analysis of HLA class II alleles and susceptibility to type I (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35, 419-424.
11. Awata, T.; Matsumoto, C.; Urakami, T.; Hagura, R.; Amemiya, S. and Kanazawa, Y. (1994a) Association of polymorphism in the interferon γ gene with IDDM. Diabetologia 37, 1159-1162.
12. Awata, T.; Matsumoto, C.; Urakami, T.; Hagura, R.; Amemiya, S. and Kanazawa, Y. (1994b) Association of polymorphism in the interferon gamma gene with IDDM. Diabetologia 37, 1159-1162.
13. Awata, T.; Shibasaki, Y.; Hirai, H.; Okabe, T.; Kanazawa, Y. and Takaku, F. (1985) Restriction fragment length polymorphism of the insulin gene region in Japanese diabetic and non-diabetic subjects. Diabetologia 28, 911-913.
14. Ban, Y.; Taniyama, M.; Tozaki, T.; Yanagawa, T.; Yamada, S.; Maruyama, T.; Kasuga, A. and Tomita, M. (2001a) No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population. Autoimmunity 34, 39-43.
15. Ban, Y.; Taniyama, M.; Yanagawa, T.; Yamada, S.; Maruyama, T. and Kasuga, A. (2001b) Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med. Genet. 2, 7.
16. Bassuny, W. M.; Mara, K.; Sasaki, Y.; Kuromaru, R.; Kohno, H.; Matsuura, N. and Hara, T. (2003) A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 55, 149-156.
17. Bottini, N.; Musumeci, L.; Alonso, A.; Rahmouni, S.; Nika, K.; Rostamkhani, M.; MacMurray, J.; Meloni, G. F.; Lucarelli, P.; Pellecchia, M.; Eisenbarth, G. S.; Comings, D. and Mustelin, T. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36, 337-338.
18. Cetkovic-Cvrlje, M.; Gerling, I. C.; Muir, A.; Atkinson, M. A.; Elliot, J. F. and Leiter, E. H. (1997) Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens. Diabetes 46, 1975-1982.
19. Concannon, P.; Gogolin-Ewens, K. J.; Hinds, D. A.; Wapelhorst, B.; Morrison, V. A.; Stirling, B.; Mitra, M.; Farmer, J.; Williams, S. R.; Cox, N. J.; Bell, G. I.; Risch, N. and Spielman, R. S. (1998) A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat. Genet. 19, 292-296.
20. Copeman, J. B.; Cucca, F.; Hearne, C. M.; Cornall, R. J.; Reed, P. W.; Ronningen, K. S.; Undlien, D. E.; Nistico, L.; Buzzetti, R.; Tosi, R.; Pociot, F.; Nerup, J.; Cornelis, F.; Barnett, A. H.; Bain, S. C. and Todd, J. A. (1995) Linkage disequilibrium mapping of a type I diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nature Genet. 9, 80-85.
21. Cucca, F.; Goy, J. V.; Kawaguchi, Y.; Esposito, L.; Merriman, M. E.; Wilson, A. J.; Cordell, H. J.; Bain, S. C. and Todd, J. A. (1998) A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat Genet. 19, 301-302.
22. Daniel, D. and Wegmann, D. R. (1996) Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. 93, 956-960.
23. Davies, J. L.; Kawaguchi, Y.; Bennett, S. T.; Copeman, J. B.; Cordell, H. J.; Pritchard, L. E.; Reed, P. W.; Gough, S. C. L.; Jenkins, S. C.; Palmer, S. M.; Balfour, K. M.; Rowe, B. R.; Farrall, M.; Barnett, A. H.; Bain, S. C. and Todd, J. A. (1994) A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371, 130-136.
24. Delepine, M.; Pociot, F.; Habita, C.; Hashimoto, L.; Frougel, P.; Rotter, J.; Cambon-Thomsen, A.; Deschamps, I.; Djoulah, S.; Weissenbach, J.; Nerup, J.; Lathrop, M. and Julier, C. (1997) Evidence of a non-MHC susceptiblity locus in type I diabetes linked to HLA on chromosome 6. Am. J. Hum. Genet. 60, 174-187.
25. Delrieu, O.; Dubois-Laforgue, D.; Timsit, J.; Tournier-Lasserve, E. and Caillat-Zucman, S. (2001) A dinucleotide repeat polymorphism at the poly(ADP-ribose) polymerase gene is not associated with predisposition to type 1 diabetes in French Caucasians. J. Autoimmun. 17, 137-140.
26. Diabetes Prevention Trial- Type 1 Diabetes Study Group. (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med. 346, 1685-1691.
27. Dubois-Laforgue, D.; Hendel, H.; Caillat-Zucman, S.; Zagury, J. F.; Winkler, C.; Boitard, C. and Timsit, J. (2001) A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 50, 1211-1213.
28. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. (2004) European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363, 925-931.
29. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197.
30. Field, L. L. (2002) Genetic linkage and association studies of Type I diabetes: challenges and rewards. Diabetologia 45, 21-35.
31. Field, L. L.; Tobias, R. and Magnus, T. (1994) A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nature Genet. 8, 189-194.
32. Field, L. L.; Tobias, R.; Thomson, G. and Plon, S. (1996) Susceptibility to insulin-dependent diabetes mellitus maps to a locus(IDDM11) on human chromosome 14q24.3-q31. Genomics 33, 1-8.
33. Fougerousse, F.; Meloni, R.; Roudaut, C. and Beckmann, J. S. (1992) Dinucleotide repeat polymorphism at the human poly (ADP-ribose) polymerase gene (PPOL). Nucleic Acids Res. 20, 1166.
34. Gale, E. A. (1996) Theory and practice of nicotinamide trials in pre-type 1 diabetes. J. Pediatr. Endocrinol. Metab. 9, 375-379.
35. Hamaguchi, K.; Kimura, A.; Seki, N.; Higuchi, T.; Yasunaga, S.; Takahashi, M.; Sasazuki, T.; Kusuda, Y.; Okeda, T.; Itoh, K. and Sakata, T. (2000) Analysis of tumor necrosis factor-α promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens 55, 10-16.
36. Harada, M.; Kishimoto, Y. and Makino, S. (1990) Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes 8, 85-90.
37. Hartmann, B.; Bellmann, K.; Ghiea, I.; Kleemann, R. and Kolb, H. (1997) Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant. Diabetologia 40, 902-909.
38. Hutchings, P. R. and Cooke, A. (1995) Comparative study of the protective effect afforded by intravenous administration of bovine or ovine insulin to young NOD mice. Diabetes 44, 906-910.
39. Ide, A.; Kawasaki, E.; Abiru, N.; Sun, F.; Fukushima, T.; Takahashi, R.; Kuwahara, H.; Fujita, N.; Kita, A.; Oshima, K.; Uotani, S.; Yamasaki, H.; Yamaguchi, Y.; Kawabata, Y.; Fujisawa, T.; Ikegami, H. and Eguchi, K. (2003) Stromal-cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population. Hum. Immunol. 64, 973-978.
40. Ide, A.; Kawasaki, E.; Abiru, N.; Sun, F.; Kobayashi, M.; Fukushima, T.; Takahashi, R.; Kuwahara, H.; Kita, A.; Oshima, K.; Uotani, S.; Yamasaki, H.; Yamaguchi, Y. and Eguchi, K. (2004) Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J. Autoimmun. 22, 73-78.
41. Ide, A.; Kawasaki, E.; Abiru, N.; Sun, F.; Takahashi, R.; Kuwahara, H.; Fujita, N.; Kita, A.; Oshima K.; Sakamaki, H.; Uotani, S.; Yamasaki, H.; Yamaguchi, Y. and Eguchi, K. (2002) Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum. Immunol. 63, 690-695.
42. Ihara, K.; Ahmed, S.; Nakao, F.; Kinukawa, N.; Kuromaru, R.; Matsuura, N.; Iwata, I.; Nagafuchi, S.; Kohno, H.; Miyako, K. and Hara, T. (2001) Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics 53, 447-454.
43. Ikegami, H. and Ogihara, T. (1996) Genetics of insulin-dpendent diabetes mellitus. Endocrine J. 43, 605-613.
44. Iwata, I.; Nagafuchi, S.; Nakashima, H.; Kondo, S.; Koga, T.; Yokogawa, Y.; Akashi, T.; Shibuya, T.; Umeno, Y.; Okeda, T.; Shibata, S.; Kono, S.; Yasunami, M.; Ohkubo, H. and Niho, Y. (1999) Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes 48, 416-419.
45. Karvonen, M.; Tuomilehto, J.; Libman, I.; LaPorte, R. and Group, W. D. P. (1993) A review of the recent epidemiological data on the worldwide incidence of Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36, 883-892.
46. Kaufman, D. L.; Clare-Salzler, M.; Tian, J.; Forsthuber, T.; Ting, G. S. P.; Robinson, P.; Atkinson, M. A.; Sercarz, E. E.; Tobin, A. J. and Lehmann, P. V. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366, 69-72.
47. Kawabata, Y.; Ikegami, H.; Kawaguchi, Y.; Fujisawa, T.; Hotta, M.; Ueda, H.; Shintani, M.; Nojima, K.; Ono, M.; Nishino, M.; Taniguchi, H.; Noso, S.; Yamada, K.; Babaya, N. and Ogihara, T. (2000) Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. Hum. Immunol. 61, 624-629.
48. Kawabata, Y.; Ikegami, H.; Kawaguchi, Y.; Fujisawa, T.; Shintani, M.; Ono, M.; Nishino, M.; Uchigata, Y.; Lee, I. and Ogihara, T. (2002) Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 51, 545-551.
49. Kawasaki, E. and Eisenbarth, G. S. (1996) Multiple autoantigens in the prediction and pathogenesis of type I diabetes. Diab. Nutr. Metab. 9, 188-198.
50. Kawasaki, E. and Eisenbarth, G. S. (2000) High-throughput radioassays for autoantibodies to recombinant autoantigens. Front. Biosci. 5, E181-E190.
51. Kida, K.; Mimura, G.; Kobayashi, T.; Nakamura, K.; Sonoda, S.; Inouye, H. and Tsuji, K. (1989) Immunogenetic heterogeneity in type 1 (insulin-dependent) diabetes among Japanese: HLA antigens and organ-specific autoantibodies. Diabetologia 32, 34-39.
52. Kouki, T.; Sawai, Y.; Gardine, C. A.; Fisfalen, M. E.; Alegre, M. L. and DeGroot, L. J. (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J. Immunol. 165, 6606-6611.
53. Kretowski, A.; Mironczuk, K.; Karpinska, A.; Bojaryn, U.; Kinalski, M.; Puchalski, Z. and Kinalska, I. (2002) Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 51, 3347-3349.
54. Lampeter, E. F.; Klinghammer, A.; Scherbaum, W. A.; Heinze, E.; Haastert, B.; Giani, G. and Kolb, H. (1998) The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes 47, 980-984.
55. Luo, D. F.; Bui, M. M.; Muir, A.; Maclaren, N. K.; Thomson, G. and She, J. X. (1995) Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am. J. Hum. Genet. 57, 911-919.
56. Marron, M. P.; Raffel, L. J.; Garchon, H. J.; Jacob, C. O.; Serrano-Rios, M.; Martinez, L. M. T.; Teng, W. P.; Park, Y.; Zhang, Z. X.; Goldstein, D. R.; Tao, Y. W.; Beaurain, G.; Bach, J. F.; Huang, H. S.; Luo, D. F.; Zeidler, A.; Rotter, J. I.; Yang, M. C.; Modilevsky, T.; Maclaren, N. K. and She, J. X. (1997) Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet. 6, 1275-1282.
57. Mathieu, C.; Laureys, J.; Sobis, H.; Vandeputte, M.; Waer, M. and Bouillon, R. (1992) 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41, 1491-1495.
58. Matsuura, N.; Fukuda, K.; Okuno, A.; Harada, S.; Fukushima, N.; Koike, A.; Ito, Y. and Hotsubo, T. (1998) Descriptive epidemiology of IDDM in Hokkaido, Japan: the Childhood IDDM Hokkaido Registry. Diabetes Care 21, 1632-1636.
59. Mein, C. A.; Esposito, L.; Dunn, M. G.; Johnson, G. C.; Timms, A. E.; Goy, J. V.; Smith, A. N.; Sebag-Montefiore, L.; Merriman, M. E.; Wilson, A. J.; Pritchard, L. E.; Cucca, F.; Barnett, A. H.; Bain, S. C. and Todd, J. A. (1998) A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat. Genet. 19, 297-300.
60. Merriman, T.; Twells, R.; Merriman, M.; Eaves, I.; Cox, R.; Cucca, F.; McKinney, P.; Shield, J.; Baum, D.; Bosi, E.; Pozzilli, P.; Nistico, L.; Buzzetti, R.; Joner, G.; Ronningen, K.; Thorsby, E.; Undlien, D.; Pociot, F.; Nerup, J.; Bain, S.; Barnett, A. and Todd, J. (1997) Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q2l. Hum. Mol. Genet. 6, 1003-1010.
61. Morahan, G.; Huang, D.; Tait, B. D.; Colman, P. G. and Harrison, L. C. (1996) Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 272, 1811-1813.
62. Morahan, G.; Huang, D.; Ymer, S. I.; Cancilla, M. R.; Stephen, K.; Dabadghao, P.; Werther, G.; Tait, B. D.; Harrison, L. C. and Colman, P. G. (2001) Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat. Genet. 27, 218-221.
63. Muir, A.; Peck, A.; Clare-Salzler, M.; Song, Y.; Cornelius, J.; Luchetta, R.; Krischer, J. and Maclaren, N. (1995) Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J. Clin. Invest. 95, 628-634.
64. Nishino, M.; Ikegami, H.; Kawaguchi, Y.; Fujisawa, T.; Kawabata, Y.; Shintani, M.; Ono, M.; Horiki, M.; Kawasaki, E. and Ogihara, T. (2001) Polymorphism in gene for islet autoantigen, IA-2, and type 1 diabetes in Japanese subjects. Hum. Immunol. 62, 518-522.
65. Nistico, L.; Buzzetti, R.; Pritchard, L. E.; Van der Auwera, B.; Giovannini, C.; Bosi, E.; Larrad, M. T. M.; Rios, M. S.; Chow, C. C.; Cockram, C. S.; Jacobs, K.; Mikovic, C.; Bain, S. C.; Barnett, A. H.; Vandewalle, C. L.; Schuit, F.; Gorus, F. K.; Registry, B. D.; Tosi, R.; Pozzilli, P. and Todd, J. A. (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type I diabetes. Hum. Mol. Genet. 5, 1075-1080.
66. Norman, A. W.; Frankel, J. B.; Heldt, A. M. and Grodsky, G. M. (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209, 823-825.
67. Park, Y.; Lee, H.; Koh, C. S.; Min, H.; Zimmet, P. Z.; Rowley, M. J.; Mackay, I. R.; Trucco, M. and Dorman, J. S. (1996) Low prevalence of immunogenetic markers of IDDM in adult Koreans with diabetes detected on OGTT. Diabetes Res. Clin. Pract. 34, S37-S43.
68. Pociot, F.; Wilson, A. G.; Nerup, J. and Duff, G. W. (1993) No independent association between a tumor necrosis factor-α promotor region polymorphism and insulin-dependent diabetes mellitus. Eur. J. Immunol. 23, 3050-3053.
69. Reed, P.; Cucca, F.; Jenkins, S.; Merriman, M.; Wilson, A.; McKinney, P.; Bosi, E.; Joner, G.; Ronningen, K.; Thorsby, E.; Undlien, D.; Merriman, T.; Barnett, A.; Bain, S. and Todd, J. (1997) Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. Hum. Mol. Genet. 6, 1011-1016.
70. Rowe, R.E.; Wapelhorst, B.; Bell, G. I.; Risch, N.; Speilman, R. S. and Concannon, P. (1995) Linkage and association between insulin-dependent diabetes mellitus (IDDM) susceptibility and markers near the glucokinase gene on chromosome 7. Nature Genet. 10, 240-242.
71. Sadelain, M. W.; Qin, H. Y.; Sumoski, W.; Parfrey, N.; Singh B. and Rabinovitch, A. (1990a) Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J. Autoimmun. 3, 671-680.
72. Sadelain, M. W. J.; Qin, H.; Lauzon, J. and Singh, B. (1990b) Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39, 583-589.
73. Takeda, J.; Seino, Y.; Fukumoto, H.; Koh, G.; Otsuka, A.; Ikeda, M.; Kuno, S.; Yawata, M.; Moridera, K.; Morita, T.; Tsuda, K. and Imura, H. (1986) The polymorphism linked to the human insulin gene: its lack of association with either IDDM or NIDDM in Japanese. Acta Endocrinol. (Copenh) 113, 268-271.
74. Tisch, R.; Liblau, R. S.; Yang, X. D.; Liblau, P. and McDevitt, H. O. (1998) Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 47, 894-899.
75. Tuomi, T.; Group, L. C.; Zimmet, P. Z.; Rowley, M. J.; Knowles, W. J. and Mackay, I. R. (1993) Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes in adults with a non-insulin-dependent onset of diabetes. Diabetes 42, 359-362.
76. Tuomilehto, J.; Virtala, E.; Karvonen, M.; Lounamaa, R.; Pitkaniemi, J.; Reunanen, A.; Tuomilehto-Wolf, E.; Toivanen, L. and group t.D.s. (1995) Increase in incedence of insulin-dependent diabetes mellitus among children in Finland. Int. J. Epidemiol. 24, 984-992.
77. Uchigata, Y.; Yamamoto, H.; Nagai, H. and Okamoto, H. (1983) Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes 32, 316-318.
78. Vafiadis, P.; Bennett, S. T.; Todd, J. A.; Nadeau, J.; Grabs, R.; Goddyer, C. G.; Wickramasinghe, S.; Colle, E. and Polychronakos, C. (1997) Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15, 289-292.
79. Vella, A.; Howson, J. M.; Barratt, B. J.; Twells, R. C.; Rance, H. E.; Nutland, S.; Tuomilehto-Wolf, E.; Tuomilehto, J.; Undlien, D. E.; Ronningen, K. S.; Guja, C.; Ionescu-Tirgoviste, C.; Savage, D. A. and Todd, J. A. (2004) Lack of association of the Ala(45)Thr polymorphism and other common variants of the NeuroD gene with type 1 diabetes. Diabetes 53, 1158-1161.
80. Verge, C. F.; Gianani, R.; Kawasaki, E.; Yu, L.; Pietroapolo, M.; Jackson, R. A.; Chase, H. P, and Eisenbarth, G. S. (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45, 926-933.
81. Verge, C. F.; Vardi, P.; Babu, S.; Bao, F.; Erlich, H. A.; Bugawan, T.; Tiosano, D.; Yu, L.; Eisenbarth, G. S. and Fain, P. R. (1998) Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family. J. Clin. Invest. 102, 1569-1575.
82. Yamada, S.; Motohashi, Y.; Yanagawa, T.; Maruyama, T.; Kasuga, A.; Hirose, H.; Matsubara, K.; Shimada, A. and Saruta, T. (2001) NeuroD/beta2 gene G→A polymorphism may affect onset pattern of type 1 diabetes in Japanese. Diabetes Care 24, 1438-1441.
83. Yasunaga, S.; Kimura, A.; Hamaguchi, K.; Ronningen, K. S. and Sasazuki, T. (1996) Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 47, 37-48.
84. Zimmet, P. Z.; Tuomi, T.; Mackay, I. R.; Rowley, M. J.; Knowles, W.; Cohen, M. and Lang, D. A. (1994) Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet. Med. 11, 299-303.